Tag: genomics
-
Here’s What a Real Opioid Emergency Looks Like
Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency.
-
Roche, Biotech to Discover New Antibiotics
A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics.
-
Biotech Licenses Gene Editing for Autoimmune Disorders
A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases.
-
Algorithms ID Factors in Parkinson’s Progression
Data from two clinical trials analyzed with machine learning algorithms identify factors that predict the decline of motor functions in individuals with Parkinson’s disease.
-
Chip Device Finds, Collects Circulating Tumor Cells
A multi-disciplinary team designed a lab-on-a-chip device using hydrodynamic forces to find and help identify circulating tumor cells in blood samples.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
University, Drug Maker Partner on Suicide Genetics
Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.
-
Field Tests of Genetically Modified Moths to Begin
Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway.
-
Simple Cell Programming Designed for Gene Therapies
A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia.